SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sequent Scientific informs about acquisition

02 Mar 2022 Evaluate

With reference to its announcement dated December 16, 2021, on proposed acquisition of 100% stake in Nourrie Saúde e Nutrição Animal ('Nourrie') through Alivira Saúde Animal, Brazil, (erstwhile known as Evance Saude Animal Health), wholly owned subsidiary of the Company, Sequent Scientific has informed that the said transaction has been completed. On completion of the said transaction, Nourrie has become a Wholly Owned Subsidiary of Alivira Saúde Animal and consequently of the Company. A press being issued by the Company is also attached.

The above information is a part of company’s filings submitted to BSE.

Viyash Scientific Share Price

208.90 0.05 (0.02%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×